Research Paper Volume 13, Issue 17 pp 21671—21699

Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer


Figure 2. The protein expression level of TfR1 in BC. (A) TfR1 expression at the protein level in BC tissues (n = 125) and normal breast tissues (n = 18) through UALCAN database. (B) TfR1 protein expression was investigated in patients with different stages of BC (normal individuals, n = 18; stage 1, n = 4; stage 2, n = 74; and stage 3, n = 32). (C) The protein expressions of TfR1 were evaluated using the HPA database. The results of IHC staining suggested that the TfR1 protein was expressed at high levels in BC tissues. *< 0.05, **< 0.01.